Microsoft To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Friday

Keybanc boosted the price target for Spotify Technology S.A. SPOT from $180 to $205. Keybanc analyst Justin Patterson maintained an Overweight rating. Spotify shares rose 0.9% to $172.68 in pre-market trading.
Morgan Stanley boosted Boyd Gaming Corporation BYD price target from $69 to $75. Morgan Stanley analyst Stephen Grambling upgraded the stock from Underweight to Equal-Weight. Boyd Gaming shares rose 1.9% to close at $71.43 on Thursday.
Chardan Capital increased the price target for Ouster, Inc. OUST from $1 to $10. Chardan Capital analyst Brian Dobson upgraded the stock from Neutral to Buy. Ouster shares rose 4.8% to $6.53 in pre-market trading.
Raymond James slashed the price target for NOV Inc. NOV from $29 to $27. Raymond James analyst Praveen Narra maintained an Outperform rating. NOV shares rose 0.1% to $18.50 in pre-market trading.
Stephens & Co. raised McDonald's Corporation MCD price target from $300 to $325. Stephens & Co. analyst Joshua Long maintained an Overweight rating. McDonald's shares fell 0.1% to close at $295.22 on Thursday.
Needham boosted Coinbase Global, Inc. COIN price target from $70 to $120. Needham analyst John Todaro maintained a Buy rating. Coinbase shares fell 1.1% to $105.80 in pre-market trading.
JP Morgan cut AT&T Inc. T price target from $22 to $17. JP Morgan analyst Philip Cusick downgraded the stock from Overweight to Neutral. AT&T shares fell 1.3% to $14.93 in pre-market trading.
UBS boosted Microsoft Corporation MSFT price target from $345 to $400. UBS analyst Karl Keirstead upgraded the stock from Neutral to Buy. Microsoft shares rose 1.6% to close at $342.66 on Thursday.
Baird raised the price target for Albany International Corp. AIN from $101 to $120. Baird analyst Peter Arment upgraded the stock from Neutral to Outperform. Albany International shares rose 1.2% to $92.15 in pre-market trading.
HC Wainwright & Co. increased ACADIA Pharmaceuticals Inc. ACAD price target from $28 to $33. HC Wainwright & Co. analyst Andrew Fein maintained a Buy rating. ACADIA Pharmaceuticals shares gained 20.4% to $31.06 in pre-market trading.
Stephens & Co. boosted Starbucks Corporation SBUX price target from $103 to $110. Stephens & Co. analyst Joshua Long maintained an Equal-Weight rating. Starbucks shares fell 0.2% to $101.45 in pre-market trading.